&gt; The claim of losing money is almost certainly a lie. The marginal cost of a drug like this is usually almost nothing.<p>Spoken like someone who has never worked on low-volume production before.  Fixed costs that amortize to trivial amounts when producing a few million or billion doses a year get significant when amortized across a few thousand.<p><i>I</i> don&#x27;t buy the article&#x27;s unsourced assertion that the medication only costs $230&#x2F;dose to make.  Assuming 4,000 doses&#x2F;year (800 patients * 5 doses&#x2F;patient [$23,000&#x2F;dose &#x2F; &quot;over $100,000 per infant&quot;]), that&#x27;s a production cost of only $920,000.  The cost of regulatory compliance <i>alone</i> is probably greater than that.